肝细胞特异性对比剂钆塞酸二钠评估2018版肝脏影像报告和数据系统主要征象的问题和陷阱

Problems and pitfalls of the hepatocyte-specific contrast agent gadoxetate disodium for assessing the main criteria of LI-RADS version 2018

虽然肝脏影像报告与数据系统中有对其主要征象:动脉期非环状强化、非周边廓清、强化包膜、病变大小及阈值增长的定义和解释,但在临床工作中基于钆塞酸二钠评估主要征象时仍有一些问题与陷阱需要临床医师与放射科医师了解与规避。现就基于肝细胞对比剂钆塞酸二钠评估主要征象时存在的问题和目前的解决方法予以综述。

Although main criteria like non-rim enhancement in the arterial phase,non-peripheral washout,enhancing envelope,lesion size,and threshold growth have definitions and interpretations in the Liver Imaging Reporting and Data System,there are still some problems and pitfalls that clinicians and radiologists need to understand and avoid when assessing the main criteria based on gadoxetate disodium in clinical work-up.This article reviews the existing problems and current solutions in the assessment of the main criteria based on the hepatic contrast agent gadoxetate disodium.